Ferguson Wellman Capital Management Inc. Reduces Stake in DaVita Inc. (NYSE:DVA)

Ferguson Wellman Capital Management Inc. reduced its position in DaVita Inc. (NYSE:DVA) by 7.7% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 1,500 shares of the company’s stock after selling 125 shares during the period. Ferguson Wellman Capital Management Inc.’s holdings in DaVita were worth $246,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bessemer Group Inc. boosted its stake in shares of DaVita by 2,335.6% in the 1st quarter. Bessemer Group Inc. now owns 10,741 shares of the company’s stock worth $1,483,000 after buying an additional 10,300 shares during the last quarter. Sei Investments Co. raised its holdings in DaVita by 21.3% in the 1st quarter. Sei Investments Co. now owns 41,952 shares of the company’s stock worth $5,790,000 after purchasing an additional 7,371 shares during the period. BOKF NA raised its holdings in DaVita by 286,550.0% in the 1st quarter. BOKF NA now owns 5,733 shares of the company’s stock worth $790,000 after purchasing an additional 5,731 shares during the period. Assenagon Asset Management S.A. raised its holdings in DaVita by 29.6% in the 2nd quarter. Assenagon Asset Management S.A. now owns 50,096 shares of the company’s stock worth $6,942,000 after purchasing an additional 11,454 shares during the period. Finally, Comerica Bank raised its holdings in DaVita by 41.4% in the 1st quarter. Comerica Bank now owns 34,431 shares of the company’s stock worth $4,753,000 after purchasing an additional 10,074 shares during the period. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at DaVita

In related news, CEO Javier Rodriguez sold 32,176 shares of DaVita stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $155.93, for a total value of $5,017,203.68. Following the completion of the transaction, the chief executive officer now owns 905,659 shares in the company, valued at approximately $141,219,407.87. This trade represents a 3.43 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Joel Ackerman sold 64,029 shares of DaVita stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $155.06, for a total value of $9,928,336.74. Following the completion of the transaction, the chief financial officer now owns 111,481 shares of the company’s stock, valued at approximately $17,286,243.86. This represents a 36.48 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 156,086 shares of company stock valued at $24,807,161. 2.00% of the stock is currently owned by insiders.

Analysts Set New Price Targets

DVA has been the topic of a number of recent research reports. Barclays raised their target price on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. TD Cowen raised their target price on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, July 24th. Truist Financial raised their price target on DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. Bank of America raised their price target on DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a report on Wednesday, August 7th. Finally, UBS Group raised their price target on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, DaVita currently has an average rating of “Hold” and a consensus target price of $161.80.

DaVita Trading Down 1.8 %

Shares of DVA stock opened at $154.38 on Friday. DaVita Inc. has a 12-month low of $91.87 and a 12-month high of $168.50. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. The stock’s 50-day moving average price is $157.57 and its 200-day moving average price is $147.35. The stock has a market capitalization of $12.66 billion, a price-to-earnings ratio of 16.65, a price-to-earnings-growth ratio of 0.89 and a beta of 0.89.

DaVita (NYSE:DVA) last issued its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period last year, the firm posted $2.85 earnings per share. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. Equities research analysts predict that DaVita Inc. will post 9.71 EPS for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.